Switch Therapeutics is developing biomarker-gated, innovative genetic medicines to transform the treatment of central nervous system diseases using their proprietary Conditionally Activated siRNA (CASi) platform
Switch Therapeutics is developing biomarker-gated, innovative genetic medicines to transform the treatment of central nervous system diseases using their proprietary Conditionally Activated siRNA (CASi) platform.